HUM vs MTNB · P/E 39, rev $117.76B vs rev $1.1M
Humana Inc (HUM) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the HUM and MTNB stock pages for the full models.
Not investment advice.